Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Fulcrum Therapeutics, Inc. FULC

Set alert

Price alert · FULC

All alert types
3.74 USD +0.08 +2.33%

As of Nov 3, 11:44 AM ET

Bid
3.73 × 2
Ask
3.74 × 2
3.69 Day range 3.75
2.83 52-week range 15.74
YTD
-66.98%
1 year
-58.59%
Open
3.69
Prev close
3.65
Mkt cap
285.29M
Vol
403.22K
Avg vol
1.52M
EPS
-1.21
P/E
0.00
Div yield
0.00%
More statistics
Low
3.69
High
3.75
Forward P/E
-3.84
Beta
2.23
Short ratio
7.67
Inst. own
89.70%
Dividend
0.00
Ex-div date
Earnings
Jul 31, 2024
50-d avg
3.58
200-d avg
6.57
1y target
5.29

3M chart

Chart tools
Interval
1m5m15m30m

Signals (17)
NameDateAgo
SMA: BullishNov 3, 20262 hours ago
SMA: BearishOct 30, 20264 days ago
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 29, 20265 days ago
SMA: BullishOct 28, 20266 days ago
MACD: Buy SignalOct 27, 20261 week ago
MACD: Sell SignalOct 26, 20261 week ago
MACD: Buy SignalOct 20, 20262 weeks ago
MACD: Sell SignalOct 14, 20262 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
SMA: BearishSep 25, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago

Analyst view

Price target (mean) 5.29 +41.5% upside
Target (low)
2.00
Target (mean)
5.29
Target (high)
14.00
Ratings (0m) 8 2 buy · 5 hold · 1 sell
  • Strong buy1
  • Buy1
  • Hold5
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

FULC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.28714-0.34 – -0.23-0.40+28.2%0-100.0%7
Next quarter-0.2625-0.30 – -0.22-0.43+39.0%00.0%4
Current year-0.14833-0.24 – -0.08-1.59+90.7%80.40M+2766.5%6
Next year-1.05-1.51 – -0.81-0.14833-609.8%0-100.0%7

Upgrades and downgrades

The latest rating changes

FULC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024RBC CapitalReiteratedSector PerformSector Perform
Nov 14, 2024HC Wainwright & Co.ReiteratedNeutralNeutral
Sep 13, 2024RBC CapitalDowngradeOutperformSector Perform
Sep 13, 2024HC Wainwright & Co.DowngradeBuyNeutral
Sep 12, 2024Leerink PartnersDowngradeOutperformMarket Perform
Sep 12, 2024B of A SecuritiesDowngradeNeutralUnderperform
Sep 12, 2024StifelDowngradeBuyHold
Sep 12, 2024Cantor FitzgeraldDowngradeOverweightNeutral
Sep 9, 2024B of A SecuritiesUpgradeUnderperformNeutral
Aug 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 10, 2024Cantor FitzgeraldReiteratedOverweightOverweight
May 20, 2024Cantor FitzgeraldInitiated—Overweight
May 14, 2024Goldman SachsUpgradeNeutralBuy
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2024OppenheimerMaintainedOutperformOutperform
May 13, 2024Goldman SachsUpgradeNeutralBuy
Mar 13, 2024RBC CapitalInitiated—Outperform
Feb 28, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 28, 2024Piper SandlerMaintainedOverweightOverweight
Jan 26, 2024Goldman SachsMaintainedNeutralNeutral
Jan 25, 2024Goldman SachsMaintainedNeutralNeutral
Sep 25, 2023Goldman SachsInitiated—Neutral
Aug 23, 2023HC Wainwright & Co.UpgradeNeutralBuy
Aug 22, 2023OppenheimerReiteratedOutperformOutperform
Aug 22, 2023StifelUpgradeHoldBuy
Aug 4, 2023HC Wainwright & Co.ReiteratedNeutralNeutral
May 16, 2023OppenheimerMaintainedOutperformOutperform
May 16, 2023HC Wainwright & Co.MaintainedNeutralNeutral
May 5, 2023Goldman SachsMaintained—Neutral
May 4, 2023Goldman SachsDowngradeBuyNeutral